Company / Shareholders' Equity
Immunocore Holdings plc Shareholders' Equity History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$381.0M
FY2025
5-year range
$233.7M / $381.0M
FY2021-FY2025
Trend
+5.6%
vs FY2024
Sector context
#112 of 213
Health Care
What the data says
At $381M, Immunocore Holdings plc's shareholders' equity ranks #112 of 213 in the Health Care sector. Improved from $369M to $381M over the past 2 years.
Based on SEC 10-K filings.
$381M in FY2025 with a 3-year CAGR of +4.0%.
Improved from $369M to $381M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +4.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#112 of 213 in Health CareTop 53% of 213This company $381.0M Sector average $2.5B
▼
-85.1% below sector average
Key checks
Key Insights
- 3-year CAGR of +4.0%, indicating consistent growth.
- In FY2025, shareholders' equity increased 5.6% year-over-year.
- Ranks #112 out of 213 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $381.0M | +5.6% |
| FY2024 | $360.7M | -2.2% |
| FY2023 | $368.8M | +8.8% |
| FY2022 | $338.9M | +45.0% |
| FY2021 | $233.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026